
XBP1s Acts as a Tumor Suppressor to Inhibit the EMT Process and Metastasis of Papillary Thyroid Cancer
Author(s) -
Wen Yang,
Xia Xu,
Ming Xu,
Jun Zhou,
Zihan Xi,
Hui Guo,
Jie Ming,
Tao Huang
Publication year - 2021
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s297046
Subject(s) - cancer research , medicine , metastasis , epithelial–mesenchymal transition , thyroid cancer , immunohistochemistry , lymph node , thyroid carcinoma , cancer , oncology , thyroid , pathology
Papillary thyroid cancer (PTC) patients could obtain poor prognosis if they have lymph node metastasis, identification of informative and robust biomarkers for predicting cervical lymph node metastasis is critical for improving clinical decision-making and patient prognosis.